HomeCompareHEJD vs JNJ

HEJD vs JNJ: Dividend Comparison 2026

HEJD yields 3.78% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HEJD wins by $5.5K in total portfolio value
10 years
HEJD
HEJD
● Live price
3.78%
Share price
$27.42
Annual div
$1.04
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.6K
Annual income
$481.49
Full HEJD calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — HEJD vs JNJ

📍 HEJD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHEJDJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HEJD + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HEJD pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HEJD
Annual income on $10K today (after 15% tax)
$321.07/yr
After 10yr DRIP, annual income (after tax)
$409.27/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $294.35/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HEJD + JNJ for your $10,000?

HEJD: 50%JNJ: 50%
100% JNJ50/50100% HEJD
Portfolio after 10yr
$22.8K
Annual income
$654.63/yr
Blended yield
2.87%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

HEJD
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HEJD buys
0
JNJ buys
0
No recent congressional trades found for HEJD or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHEJDJNJ
Forward yield3.78%3.36%
Annual dividend / share$1.04$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$25.6K$20.0K
Annual income after 10y$481.49$827.78
Total dividends collected$4.3K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: HEJD vs JNJ ($10,000, DRIP)

YearHEJD PortfolioHEJD Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,078$377.73$10,676$355.77+$402.00HEJD
2$12,244$391.07$11,407$389.39+$837.00HEJD
3$13,505$403.97$12,198$426.53+$1.3KHEJD
4$14,867$416.42$13,056$467.62+$1.8KHEJD
5$16,336$428.42$13,987$513.12+$2.3KHEJD
6$17,920$439.96$14,998$563.56+$2.9KHEJD
7$19,625$451.04$16,098$619.52+$3.5KHEJD
8$21,461$461.65$17,295$681.69+$4.2KHEJD
9$23,435$471.80$18,599$750.82+$4.8KHEJD
10$25,556$481.49$20,022$827.78+$5.5KHEJD

HEJD vs JNJ: Complete Analysis 2026

HEJDStock

About HEJD Invests in U.S. dividend-paying stocks while shorting highly correlated equity index futures, in an effort to offset market risk providing a consistent hedge that is adjusted with market movements. Seeks equity market participation with risk mitigation designed to reduce volatility and downside capture relative to traditional long-only strategies. Offers diversification by providing modest correlation to the U.S. equity market and low correlation to fixed income. Seeks income in addition to its main objective of providing capital appreciation. A highly systematic, transparent and liquid alternative investment with active oversight.

Full HEJD Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this HEJD vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HEJD vs SCHDHEJD vs JEPIHEJD vs OHEJD vs KOHEJD vs MAINHEJD vs ABBVHEJD vs MRKHEJD vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.